APA

Vardhanabhuti S., Ribaudo H. J., Landovitz R. J., Ofotokun I., Lennox J. L., Currier J. S., Olson L. M. & Haas D. W. (20150716). Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia. : Open forum infectious diseases.

Chicago

Vardhanabhuti Saran, Ribaudo Heather J, Landovitz Raphael J, Ofotokun Ighovwerha, Lennox Jeffrey L, Currier Judith S, Olson Lana M and Haas David W. 20150716. Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia. : Open forum infectious diseases.

Harvard

Vardhanabhuti S., Ribaudo H. J., Landovitz R. J., Ofotokun I., Lennox J. L., Currier J. S., Olson L. M. and Haas D. W. (20150716). Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia. : Open forum infectious diseases.

MLA

Vardhanabhuti Saran, Ribaudo Heather J, Landovitz Raphael J, Ofotokun Ighovwerha, Lennox Jeffrey L, Currier Judith S, Olson Lana M and Haas David W. Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia. : Open forum infectious diseases. 20150716.